Center-Authored Papers

Filters: Author is Grandori, Carla  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bluemn EG, Spencer SE, Mecham B, Gordon RR, Coleman I, Lewinshtein D, Mostaghel E, Zhang X, Annis J, Grandori C et al..  2013.  PPP2R2C loss promotes castration-resistant prostate cancer growth and is associated with increased prostate cancer-specific mortality.. Molecular cancer research : MCR. 11(6):568-578. Abstract
C
Cermelli S, Jang IS, Bernard B, Grandori C.  2014.  Synthetic Lethal Screens as a Means to Understand and Treat MYC-Driven Cancers.. Cold Spring Harbor perspectives in medicine. 4(3) Abstract
G
Gerhard DS, Clemons PA, Shamji AF, Hon C, Wagner BK, Schreiber SL, Krasnitz A, Sordella R, Sander C, Lowe SW et al..  2016.  Transforming Big Data into cancer-relevant insight: An initial, multi-tier approach to assess reproducibility and relevance.. Molecular cancer research : MCR. Abstract
K
Kemp CJ, Grandori C.  2013.  Functional genomics to identify unforeseen cancer drug targets.. Future oncology (London, England). 9(4):473-6.
M
Mishra R, Watanabe T, Kimura MT, Koshikawa N, Ikeda M, Uekusa S, Kawashima H, Wang X, Igarashi J, Choudhury D et al..  2015.  Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation.. Cancer science. 106(4):421-9. Abstract
Moser R, Xu C, Kao M, Annis J, Lerma LA, Schaupp CM, Gurley KE, Jang IS, Biktasova A, Yarbrough WG et al..  2014.  Functional kinomics identifies candidate therapeutic targets in head and neck cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(16):4274-88. Abstract
Moser R, Toyoshima M, Robinson K, Gurley KE, Howie HL, Davison J, Morgan M, Kemp CJ, Grandori C.  2012.  MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.. Molecular cancer research : MCR. 10(4):535-45. Abstract
P
Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R et al..  2017.  Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.. Cancer discovery. Abstract
R
Robinson K, Asawachaicharn N, Galloway DA, Grandori C.  2009.  c-Myc accelerates S-Phase and requires WRN to avoid replication stress.. PloS one. 4(6):e5951. Abstract
T
Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, Frazier J, Chau NB, Loboda A, Linsley PS et al..  2012.  Functional genomics identifies therapeutic targets for MYC-driven cancer.. Proceedings of the National Academy of Sciences of the United States of America. 109(24):9545-50. Abstract
U
Uparkar U, Gurley KE, Robinson K, Girard E, Pedro K, Park J, Kemp CJ, Grandori C.  2014.  The Role and Efficacy of Retinoic Acid (Ra) and the Flt3 Inhibitor as Combination Therapy for High Risk Neuroblastoma. Pediatric Blood & Cancer. 61:S96-S96. Abstract
W
Wang ML, Walsh R, Robinson KL, Burchard J, Bartz SR, Cleary M, Galloway DA, Grandori C.  2011.  Gene expression signature of c-MYC-immortalized human fibroblasts reveals loss of growth inhibitory response to TGFβ.. Cell cycle (Georgetown, Tex.). 10(15):2540-8. Abstract
X
Xu M, Luo W, Elzi DJ, Grandori C, Galloway DA.  2008.  NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes.. Molecular and cellular biology. 28(15):4819-28. Abstract
Xu C, Nikolova O, Basom R, Mitchell RM, Shaw R, Moser R, Park H, Gurley KE, Kao M, Green CL et al..  2018.  Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 24(12):2828-2843. Abstract
Xu M, Katzenellenbogen RA, Grandori C, Galloway DA.  2010.  NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.. Journal of virology. 84(21):11461-9. Abstract
Xu M, Katzenellenbogen RA, Grandori C, Galloway DA.  2013.  An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes.. Virology. 446(1-2):17-24. Abstract